iShares Biotechnology ETF (IBB)
Exchange-Traded Funds (ETFs)
Buy
The speaker evaluates the upside potential of the fund, driven by increasing M&A activity in the biotechnology sector and diminishing drug pricing uncertainties.
Michael Yee
CNBC Television